A Phase 4 interventional study of Acetaminophen and Acetaminophen/Ibuprofen in Cesarean Section and Postoperative Pain, sponsored by Seoul National University Hospital. Recruiting at 1 site in Korea, Republic of. Open to female participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-04.
Sponsored by Seoul National University Hospital · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 118 studies testing acetaminophen in Pain, Postoperative — 11 open to participants now, 13 under way, 1 of them phase 3. Acetaminophen · Pain, Postoperative.
Among the 118 studies testing acetaminophen in Pain, Postoperative, this one is the 67th largest by planned enrollment, is one of 4 that started in 2024, is one of 53 in phase 4, reaches primary completion later than 3 of the 12 other live ones, and was the 106th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →11 of the 118 studies testing acetaminophen in Pain, Postoperative are open now, in 4 countries. Recruiting first, the newest first:
Northwestern University · Sites in United States
Ages 18–80
University of Puerto Rico · Sites in Puerto Rico
Ages 21–65
McGill University Health Centre/Research Institute of the McGill University Health Centre · Sites in Canada
Ages 18+
Rothman Institute Orthopaedics · Sites in United States
Ages 18+
Sanford Health · Sites in United States
Ages 18–80
By country, each count listing its studies:
Acetaminophen: first FDA approval 1968 (NEOPAP). What it is approved for, and how studies give it, is on its page →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 19 Years and older · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
118 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 12 · Phase 3 23 · Phase 4 53
First in 2002; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 84 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 90 across the 118 interventional studies. Of the 88 that completed or were terminated, 41 (47%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 118 have an industry lead sponsor. The 10 most frequent:
Seoul National University Hospital is the lead sponsor of 1,903 studies on the registry; 276 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
36 studies in Pain, Postoperative by Seoul National University Hospital: 10 open now, 12 under way, none of them phase 3. Of 18 finished, 0 (0%) have results posted.
Among the 36 studies in Pain, Postoperative by Seoul National University Hospital, this one is the 16th largest by planned enrollment of the 31 interventional ones that give a count, is one of 5 that started in 2024, is one of 4 in phase 4, reaches primary completion later than 4 of the 11 other live ones, and was the 30th registered.
Seoul National University Hospital’s Pain, Postoperative studies by the year they started, since 2011.
6 of the studies testing acetaminophen in Pain, Postoperative that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07571252University of Puerto RicoImpact of Preemptive Analgesia on Postoperative Pain in Orthognathic Surgery | 2026-12 |
| NCT06997016Baylor Research InstituteEnhanced Recovery After Surgery (ERAS) in Live Donor Kidney Transplant Recipients | 2027-06 |
| NCT03105518Brigham and Women's HospitalPredictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction | 2027-06-30 |
| NCT06613178McGill University Health Centre/Research Institute of the McGill University Health CentreIntravenous Acetaminophen After Cardiac Surgery - Definitive Study | 2027-07-01 |
| NCT07720791Konya City HospitalAcetaminophen vs Placebo for Postoperative Analgesia After Abdominal Surgery | 2027-07-15 |
Add all 6 to your calendar (.ics) → With an account.
Among the 118 studies testing acetaminophen in Pain, Postoperative, from their registry updates:
Among Seoul National University Hospital’s 36 in Pain, Postoperative:
This tab as a report to print or save as PDF → With an account.
The investigators aim to compare the analgesic efficacy of intravenous acetaminophen alone versus combination of acetaminophen/ibuprofen (Maxigesic®IV) in multimodal analgesia after cesarean section.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Acetaminophen
Drug: Acetaminophen/Ibuprofen
1g acetaminophen is administered during skin closure (end of operation).
Also known as: Acetaminophen #1
Drug pages: AcetaminophenStudies of AcetaminophenAcetaminophen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · IbuprofenStudies of IbuprofenIbuprofen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
A mixture of 1g acetaminophen and 300 mg ibuprofen (Maxigesic®IV) is administered during skin closure (end of operation)
Also known as: Acetaminophen/Ibuprofen #1
1g acetaminophen is administered 6 hours after the first administration.
Also known as: Acetaminophen #2
Drug pages: AcetaminophenStudies of AcetaminophenAcetaminophen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · IbuprofenStudies of IbuprofenIbuprofen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
A mixture of 1g acetaminophen and 300 mg ibuprofen (Maxigesic®IV) is administered 6 hours after the first administration.
Also known as: Acetaminophen/Ibuprofen #2
Obstetric QoR-11K score 24 hours after end of surgery
Minimum 0, poor recovery; maximum 110, good recovery
Time frame: 24 hours after end of surgery
Numeric rating scale pain score (0-10) 4 hours after end of surgery
0, no pain; 10, worst pain imaginable
Time frame: 4 hours after end of surgery
Numeric rating scale pain score (0-10) 8 hours after end of surgery
0, no pain; 10, worst pain imaginable
Time frame: 8 hours after end of surgery
Numeric rating scale pain score (0-10) 12 hours after end of surgery
0, no pain; 10, worst pain imaginable
Time frame: 12 hours after end of surgery
Numeric rating scale pain score (0-10) 24 h after end of surgery
Time frame: 24 h after end of surgery
Numeric rating scale pain score (0-10) 48 hours after end of surgery
0, no pain; 10, worst pain imaginable
Time frame: 48 hours after end of surgery
Use of patient-controlled analgesia (FTN, micrograms) during the first 24 hours after end of surgery
Time frame: 24 h after end of surgery
Use of patient-controlled analgesia (FTN, micrograms) during the first 48 hours after end of surgery
Time frame: 48 h after end of surgery
Use of rescue analgesia during the first 24 hours after end of surgery
Time frame: 24 h after end of surgery
Use of rescue analgesia during the first 48 hours after end of surgery
Time frame: 48 h after end of surgery
Wound-related complications during hospital stay, up to 5 days
Time frame: From end of surgery to patient discharge, up to 5 days
Operation time
Time frame: Duration of operation
Anesthesia time
Time frame: Duration of anesthesia
Injection level of intrathecal drug
Time frame: After arrival at the operating room
Dosage of intrathecal drug (mg, bupivacaine)
Time frame: After arrival at the operating room
Sensory blockade level by time point
Time frame: 0, 5, 10 minutes after intrathecal injection and at the end of operation
Plan to share: Undecided
No publications or documents are linked to this record.
Started Oct 2024 (actual). Primary completion is estimated for Jun 2026, 20 months after the start.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 20 months is above that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Acetaminophen · Ibuprofen
Seoul National University Hospital →